Insurers Object To $4.8M Ferring, Aventis Antitrust Deal
By Stewart Bishop ( March 27, 2013, 5:39 PM EDT) -- Aetna Inc. and other insurers on Monday told a New York federal judge they oppose the $4.75 million settlement of a proposed class action accusing Ferring BV and Aventis Pharmaceuticals Inc. of thwarting generic competition for an antidiuretic drug by fraudulently obtaining a patent for it....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.